Alerts

Edgewell Personal Care Australia Pty Ltd is recalling all unexpired batches (nine in total) due to the potential for the lotions to become separated.

Gem Care Products Pty Ltd is recalling all unexpired batches (two in total) due to the potential for the lotions to become separated.

Mindray Medical Australia Pty Ltd is conducting a product correction for the BeneHeart C Series Automated External Defibrillator (AED).

We are issuing an updated safety advisory regarding imported counterfeit unregistered melatonin products.

Information and approvals to manage Presolol 200 tablet shortage

TGA continues to see imports of counterfeit Botox vials despite a previous warning issued in July 2025.

Serious Scarcity Substitution Instrument extended due to continued shortages of HRT patch products.

Kmart Australia Ltd is recalling their Anko Small Gel Pak and Anko Large Gel Pak because they contain ethylene glycol, a toxic substance.

We have made a Serious Scarcity Substitution Instrument (SSSI) that starts on 22 December 2025 and ends on 28 April 2026. The SSSI allows a pharmacist to dispense an equivalent quantity of clonidine 100 mcg tablets, if appropriate, without a new prescription

Pharmaceutical companies Novo Nordisk and Eli Lilly are discontinuing some of their insulin products.

The company which has supplied the CellAED devices, RRR Manufacturing Pty Ltd, has gone into liquidation. The liquidators for RRR Manufacturing, are conducting a Critical Recall for all lots of the CellAED device.

Supply constraints will apply to Creon 25,000 unit and 35,000 unit capsules until 30 June 2026.

Key Sun Laboratories Pty Ltd is recalling one batch of Key Sun Kids Travel Sickness Homeopathic Product, due to the risk of a small metal wire being present in the lozenge.

Manasamitra Vakakam tablets pose a serious risk to your health and should not be taken.

Kumar Kalyan Rasa tablets pose a serious risk to your health and should not be taken.

Brahmi Vati tablets pose a serious risk to your health and should not be taken.

Pharmacists can substitute 10 mg simvastatin tablets during the shortage of the 5 mg tablets.

Vitality Brands Worldwide Pty Ltd is recalling three batches of Cancer Council Sunscreen Clear Zinc Kids SPF50+ 110g due to the potential for the product to become separated.

We have updated the product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues. This relatively new and high-profile class of medicines is used to treat type 2 diabetes mellitus and/or obesity.

Pharmacists can substitute whichever brand and strength of nicorandil is available during the shortage.

The safety information for denosumab products used to treat osteoporosis has been updated to strengthen the existing warning for multiple spinal fractures after discontinuation or delay of treatment.

Bondi Sands Pty Ltd is recalling five batches of sunscreen due to the potential for the lotions to become separated.

Product correction: Ypsomed Australia is reminding users to ensure they use a compatible smart device and operating system (OS) when using the Mylife CamAPS FX app.

We have extended the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Labetalol) Instrument 2025 (SSSI) to 31 December 2025.

Phytologic Holdings Pty Ltd is recalling one batch of Henry Blooms Infant Liquid D3 & K2 with Probiotic due to a dosing syringe error.